The comparable tumour microenvironment in sporadic and NF2 -related schwannomatosis vestibular schwannoma
Brain Communications · 01.07.2023 · 5 (4)
DOI: 10.1093/braincomms/fcad197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Communications, online erschienen am 21.07.2023. Verfasst von Grace E Gregory und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Healt…. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, NF2 BioSolutions UK and Europe, Dowager Countess Eleanor Peel Trust.
Abstract (Originalsprache)
Bilateral vestibular schwannoma is the hallmark of NF2-related schwannomatosis, a rare tumour predisposition syndrome associated with a lifetime of surgical interventions, radiotherapy and off-label use of the anti-angiogenic drug bevacizumab. Unilateral vestibular schwannoma develops sporadically in non-NF2-related schwannomatosis patients for which there are no drug treatment options available. Tumour-infiltrating immune cells such as macrophages and T-cells correlate with increased vestibular schwannoma growth, which is suggested to be similar in sporadic and NF2-related schwannomatosis tumours. However, differences between NF2-related schwannomatosis and the more common sporadic disease include NF2-related schwannomatosis patients presenting an increased number of tumours, multiple tumour types and younger age at diagnosis. A comparison of the tumour microenvironment in sporadic and NF2-related schwannomatosis tumours is therefore required to underpin the development of immunotherapeutic targets, identify the possibility of extrapolating ex vivo data from sporadic vestibular schwannoma to NF2-related schwannomatosis and help inform clinical trial design with the feasibility of co-recruiting sporadic and NF2-related schwannomatosis patients. This study drew together bulk transcriptomic data from three published Affymetrix microarray datasets to compare the gene expression profiles of sporadic and NF2-related schwannomatosis vestibular schwannoma and subsequently deconvolved to predict the abundances of distinct tumour immune microenvironment populations. Data were validated using quantitative PCR and Hyperion imaging mass cytometry. Comparative bioinformatic analyses revealed close similarities in NF2-related schwannomatosis and sporadic vestibular schwannoma tumours across the three datasets. Significant inflammatory markers and signalling pathways were closely matched in NF2-related schwannomatosis and sporadic vestibular schwannoma, relating to the proliferation of macrophages, angiogenesis and inflammation. Bulk transcriptomic and imaging mass cytometry data identified macrophages as the most abundant immune population in vestibular schwannoma, comprising one-third of the cell mass in both NF2-related schwannomatosis and sporadic tumours. Importantly, there were no robust significant differences in signalling pathways, gene expression, cell type abundance or imaging mass cytometry staining between NF2-related schwannomatosis and sporadic vestibular schwannoma. These data indicate strong similarities in the tumour immune microenvironment of NF2-related schwannomatosis and sporadic vestibular schwannoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
- Geoffrey Jefferson Brain Research Centre, The Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester, UK.
- The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
- Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
- Bioinformatics Core Facility, University of Manchester, Manchester, UK.
- Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.
ORCID-Profile: Grace E Gregory
Förderung
- Medical Research Council
- NF2 BioSolutions UK and Europe
- Dowager Countess Eleanor Peel Trust
- National Institute for Health and Care Research
- Manchester Biomedical Research Centre
Zitieren
APA
Gregory, G. E., Jones, A. P., Haley, M. J., Hoyle, C., Zeef, L. A. H., Lin, I. H., Coope, D. J., King, A. T., Evans, D. G., Paszek, P., Couper, K. N., Brough, D., & Pathmanaban, O. N. (2023). The comparable tumour microenvironment in sporadic and NF2 -related schwannomatosis vestibular schwannoma. Brain Communications, 5(4). https://doi.org/10.1093/braincomms/fcad197
Vancouver
Gregory GE, Jones AP, Haley MJ, Hoyle C, Zeef LAH, Lin IH, et al. The comparable tumour microenvironment in sporadic and NF2 -related schwannomatosis vestibular schwannoma. Brain Communications. 2023;5(4). doi:10.1093/braincomms/fcad197
BibTeX
@article{Gregory2023,
author = {Gregory, Grace E and Jones, Adam Paul and Haley, Michael J and Hoyle, Christopher and Zeef, Leo A H and Lin, I-Hsuan and Coope, David J and King, Andrew T and Evans, D Gareth and Paszek, Pawel and Couper, Kevin N and Brough, David and Pathmanaban, Omar N},
title = {The comparable tumour microenvironment in sporadic and NF2 -related schwannomatosis vestibular schwannoma},
journal = {Brain Communications},
year = {2023},
volume = {5},
number = {4},
doi = {10.1093/braincomms/fcad197}
}
EUVIMED